Physician

Peter Wrobel, M.D

According to 2025 Medicare claims, Peter Wrobel, M.D (NPI: 1396761987) practices family practice in the Marietta, GA market, with the plurality of this provider's patient population coming from Cobb, GA. This provider's primary affiliated billing organization is PETER WROBEL MD PC (NPI: 1063654929; TIN: 20-0471938) and primary practice location at 30114-2852. Wrobel is affiliated with the Complete Care Collaborative of the South (ACO ID: D0335), participating under the REACH model.

Wrobel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 346 traditional Medicare patients, billed 3,429 HCPCS/CPT codes, and received $580,967 in Medicare payments. The top billing code was 36465 (Injection of chemical agent into single incompetent vein of leg using ultrasound guidance). Part D data shows 5,644 prescription claims across 427 beneficiaries totaling $411,789 in drug costs, led by Ozempic (Semaglutide). DME data shows 125 claims. Open Payments data shows 29 records totaling $485. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $830,620 to $580,967. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,118,094 to $411,789. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $112,138 to $13,051.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	824	18,623	$830,620
2016	933	22,201	$668,828
2017	1,108	14,071	$546,559
2018	994	16,222	$718,126
2019	719	12,798	$652,728
2020	517	5,964	$571,262
2021	421	4,428	$563,226
2022	468	5,622	$390,517
2023	356	4,099	$355,792
2024	346	3,429	$580,967

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	713	20,550	$1,118,094
2016	789	18,680	$969,977
2017	825	21,399	$1,064,638
2018	930	20,440	$1,223,656
2019	697	11,646	$768,971
2020	449	5,973	$465,623
2021	361	5,124	$398,813
2022	492	5,028	$485,742
2023	617	6,543	$687,965
2024	427	5,644	$411,789

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	620	1,831	$117,813
2016	464	1,500	$75,556
2017	324	1,300	$63,428
2018	344	1,021	$68,763
2019	199	800	$49,344
2020	148	585	$23,745
2021	94	427	$20,473
2022	24	188	$15,654
2023	N/R	168	$9,066
2024	11	125	$9,121

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36465	Injection of chemical agent into single incompetent vein of leg using ultrasound guidance	78	150	$973
93970	Ultrasound study of arm or leg veins with compression and maneuvers	148	345	$132
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	78	78	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	283	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	123	382	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	53	2,102	$67,793
Mounjaro	Tirzepatide	57	1,598	$56,465
Eliquis	Apixaban	41	1,410	$27,027
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	876	25,701	$25,470
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	990	$20,927

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	29	$3,454
A7031	Face mask interface, replacement for full face mask, each	N	N/R	13	$1,936
A7030	Full face mask used with positive airway pressure device, each	N	N/R	13	$1,663
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	14	$707
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$481

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$485	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter Wrobel, M.D?

Tedicare shows public-source Medicare data for Peter Wrobel, M.D (NPI 1396761987), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter Wrobel, M.D have ACO affiliation data?

Peter Wrobel, M.D is shown with ACO affiliation data for Complete Care Collaborative of the South (REACH, ACO ID D0335).

What billing organization is linked to Peter Wrobel, M.D?

Peter Wrobel, M.D is linked to PETER WROBEL MD PC (billing NPI 1063654929) in the available physician profile data.

Does Peter Wrobel, M.D have Open Payments data?

Peter Wrobel, M.D has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.